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Abstract
Cancer registry is an important tool for any
successful cancer control program. The first formal
cancer related data from Iran were published in
1956. In 1969, observations documenting a high
incidence of esophageal cancer in the Caspian
Littoral, urged researchers to set up the first 
population-based cancer registry in this region. This
cancer registry was established jointly by University
of Tehran and the International Agency for Research
on Cancer (IARC). In 1976, another cancer registry
started its activities in Fars Province. In 1984, the
Parliament passed a bill mandating the report of all 
tissues “diagnosed or suspected as cancer tissue”
to the Ministry of Health. While only 18% of all 
estimated cancer cases were reported in first 
reports, this rate increased to 81% in 2005 In 1998, 
Tehran Population-Based Cancer Registry started to 
collect data from cases of cancer referred to the 
treatment and diagnostic facilities throughout the
Tehran metropolis. Digestive Disease Research
Center, Tehran University of Medical Sciences, 
established four new population-based cancer 
registries in Northern Iran and another in Kerman
Province in the south. These five provinces have a 
total population of about 9.5 million, and constitute
about 16% of the total population of Iran. While the
pathology-based cancer registration is in place, we
hope that the addition of the population-based
cancer registries, and establishment of new
registries in poorly-covered areas, will improve 
cancer reporting in the country.
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Introduction 
During the past century, chronic diseases,
including cancers, have emerged as among the
most challenging problems for public health 
systems in medium- and low-resource countries. 
One of the first steps in controlling the cancer
burden is to collect information about the 
incidence, type, and location of cancers, and this is
best done within the framework of cancer 
registries.1 
Cancer registry in the world 
In 1930, cancer registry was perceived as an 
effective preventing and controlling tool for
cancers. As a result, the first population based 
cancer registry units covering data derived from 
whole countries initiated in Hamburg (1927), New
York (1940), Connecticut (1941) and Denmark
(1942).1 The first cancer registry conference based
on population resources was organized in 1946.2 
The conference offered several ideas to support 
local and global establishment of cancer registry
units to WHO. These included the following: 1. 
Data collection from cancer patients are very 
profitable, 2. Data collection should be obtained in
an organized manner, and 3. Establishment of an 
international headquarters is an essential bridge to
make linkage of national and international 
statistical flow. In 1950, WHO organized a
committee to support cancer registry 
programming.3 In 1965, International Agency for
Research on Cancer (IARC) was established in 
order to specify cancer related research topics by 
WHO and in 1966, the International Association of
Cancer Registries (IACR) started its work 
officially and published its first global report,
"cancer in five continents''. Nowadays there are 
more than 200 cancer registry centers all over the 
world, but there is considerable difference in 
coverage across the world, for instance 99% of the
population in North America is covered by cancer 
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registries, while this is about 8% in Asia.1 
Cancer registry in Iran 
The first activities in Iran aiming at organizing 
cancer reporting were initiated in 1955, by the 
establishment of Cancer Institute in University of
Tehran (now the Institute is part of Tehran
University of Medical Sciences). The first formal
cancer related data from Iran were published by
Habibi in 1956.4 This report included data obtained
from years 1945–1956. Based on this report the
prevalence rates of cancers were 28/100,000 in 
south and 42/100,000 in north part of the country.
In 1969, observations documenting a high
incidence of esophageal cancer in the Caspian 
Littoral, urged researchers to set up the first 
population-based cancer registry in this region.5 
This cancer registry was established jointly by 
University of Tehran and the International Agency
for Research on Cancer (IARC). It started in the
city of Babol in Mazandaran province, on the 
Eastern side of the Caspian Littoral, and 
subsequently extended to the Western province of 
Gilan.6 Based on the data from this registry,
Mahboubi et al7 reported an incidence rate of 
higher than 100 per 100,000 person-years for 
esophageal cancer in the eastern portion close to 
Turkmenistan (now Golestan Province), 
particularly in the semidesert plain settled mainly 
by people of Turkmen ethnicity (109 per 100,000
among men and 174 per 100,000 among women). 
In 1968, another cancer registry started its 
activities in Fars Province.8 This registry collects 
data on all cases of cancer in Shiraz, which is 
situated in the south of the country. 9 These efforts
were interrupted in the early 1980s due to the
sociopolitical events in Iran, including the 
revolution and the war with Iraq. 
In 1984, the Parliament passed a bill mandating 
the report of all tissues “diagnosed or suspected as
cancer tissue” to the Ministry of Health.10 The
purpose of the bill was mentioned as promotion of 
“conducting epidemiologic research, regional
prevention programs, and extracting statistical data
on cancer patients”. Pathology centers are required
by law to report all cancer cases according to 
International Classification of Diseases-Oncology
(ICD-O). The reports have been published
regularly in Persian since 1999, and while in its 
first year, only 18% of all estimated cancer cases
were reported, this rate increased to 81% in 200511. 
In 1998, Tehran Population-Based Cancer
Registry (TPBCR), also known as Tehran
Metropolitan Area Cancer Registry (TMACR),
started to collect data from cases of cancer referred
to the treatment and diagnostic facilities 
throughout the Tehran metropolis.12 This registry is 
a collaborative program of the Cancer Institute 
Research Centre and the International Agency for 
Research on Cancer, and is funded by different 
research centers and Tehran University of Medical 
Sciences.13 
In 1992, Digestive Disease Research Center
(DDRC), was established in Tehran University of 
Medical Sciences. The Center had investigations 
on upper GI cancers as one of its main
missions,14,15 and was recognized as a WHO 
collaborating Center for research on
Gastrointestinal Cancer in the year 2006. DDRC 
established new population-based cancer registries 
in Northern Iran in collaboration with IARC,
Center for Disease Control in Iranian Ministry of 
Health and local medical sciences universities. The 
first of these registries was set up in Ardabil in the 
Northwest. The Ardabil Cancer Registry office is 
currently run by Ardabil University of Medical 
Sciences and supervised by the DDRC, and it has
been a member of IACR since 2005.16 This registry 
was extended to the east, including Gilan, 
Mazandaran17 and Golestan18 provinces. Northern 
Provinces were selected for 2 main reasons: the
high incidence of upper GI cancers reported in
these provinces and the availability of cancer
registry data of this region from the 1970s. 17,19 
Another center was established in Kerman
Province in the south-central part of Iran. This 
registry aimed at providing a comparison site for
cancer risk with the registries located in the
North.20 These five provinces have a total 
population of about 9.5 million, and constitute 
about 16% of the total population of Iran. They 
also include three major ethnic groups in the
country: Persian, Azari Turk, and Turkmen.21 All 
of these registries are now run by the local 
universities of medical sciences. In addition, other 
population based cancer registries in central and 
southern provinces have been established by Shiraz 
and Semnan Universities of Medical Sciences.9,22 
A series of reports from these registries have
been published showing a declining incidence of 
squamous cell cancer of esophagus and small 
bowel lymphoma (immunoprolifertive small 
intestinal disease) with concomitant rise in the 
incidence of colon, breast and distal esophageal 
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adenocarcinoma. Another important finding has
been a high incidence of gastric cardia
adenocarcinoma especially in North western
provinces.18–28 
Conclusion 
Population-based cancer registries, by 
definition, use multiple sources (including hospital 
records, records from diagnostic facilities and even 
death certificates) to collect cancer data.1 While 
this is usually easier to achieve in smaller
countries, a vast geographical territory such as 
Iran, with its climate and cultural diversity, may 
pose technical and logistic problems to this 
objective. Legislations in place are indeed helpful 
in establishing pathology-based registries, but they
lack direct support for multiple-source, population-
based cancer registries. While the pathology-based 
cancer registration is in place, we hope that the
addition of the population-based cancer registries,
and establishment of new registries in poorly-
covered areas, will improve cancer reporting in the
country. One problem the authors faced while 
composing this overview was the scarcity of 
published sources regarding cancer registration in 
Iran. Almost none of the registries named in this 
overview have an active website and most of them 
publish their results infrequently (if ever), or at
least their publications are not easily accessible.  
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